Fountoulakis M
F. Hoffmann-La Roche Ltd., Pharmaceutical Research-New Technologies, Basel, Switzerland.
J Biol Chem. 1992 Apr 5;267(10):7095-100.
Reduction of proteins which require disulfide bonds to be stable in the folded state is accompanied by step-wise unfolding. A soluble human interferon gamma receptor produced in Escherichia coli was used to investigate the kinetics of formation of unfolding intermediates. The protein includes 8 cysteine residues forming four disulfide bonds. It was reduced by using either dithiothreitol or the thioredoxin reduction system. Reduction with dithiothreitol resulted in formation of mainly four monomeric unfolding species as visualized by sodium dodecyl sulfate-polyacrylamide gels. The enzymatically catalyzed reaction produced only small amounts of two monomeric products and mostly delivered oligomeric and polymeric forms. In both cases, the ligand binding capacity of the receptor was significantly reduced immediately after appearance of the first intermediate. The intermediates involved interchange of disulfide bonds and did not show ligand binding capacity. Some of them were recognized by specific antibodies which detect conformational epitopes on the native interferon gamma receptor. On the basis of the antibody binding, a preliminary characterization of the formed intermediates was attempted. When the soluble receptor was reduced in the presence of denaturing agents, the reduction products were different from the unfolding intermediates generated in the absence of denaturants.
在折叠状态下需要二硫键来保持稳定的蛋白质的还原伴随着逐步展开。使用在大肠杆菌中产生的可溶性人干扰素γ受体来研究展开中间体形成的动力学。该蛋白质包含8个半胱氨酸残基,形成四个二硫键。使用二硫苏糖醇或硫氧还蛋白还原系统对其进行还原。用二硫苏糖醇还原后,通过十二烷基硫酸钠-聚丙烯酰胺凝胶观察到主要形成了四种单体展开物种。酶催化反应仅产生少量的两种单体产物,并且大多产生寡聚体和聚合物形式。在这两种情况下,受体的配体结合能力在第一个中间体出现后立即显著降低。这些中间体涉及二硫键的互换,并且不显示配体结合能力。其中一些被检测天然干扰素γ受体上构象表位的特异性抗体识别。基于抗体结合,尝试对形成的中间体进行初步表征。当在变性剂存在下还原可溶性受体时,还原产物不同于在没有变性剂的情况下产生的展开中间体。